信捷電氣(603416.SH):德道知味完成私募投資基金備案
格隆匯12月24日丨信捷電氣(603416.SH)公佈,公司在確保日常經營資金需求,總體投資風險可控的前提下為了進一步拓展投資領域,充分利用專業機構的經驗和資源,作為有限合夥人以自有資金出資人民幣2000萬元,參與投資濟南德道知味股權投資合夥企業(有限合夥)(以下簡稱“德道知味”)。
2019年11月22日,德道知味完成工商登記手續,取得了濟南市章丘區行政審批服務局頒發的《營業執照》。近日,公司收到基金管理人北京德道厚生投資管理有限公司的通知,德道知味已根據相關法律法規的要求,在中國證券投資基金業協會完成濟南德道知味股權投資合夥企業(有限合夥)私募投資基金備案手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.